Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial.
暂无分享，去创建一个
P. Serruys | J. Tijssen | P. Jüni | S. Garg | I. Édes | P. Steg | C. Hamm | F. Verheugt | P. Chichareon | R. Modolo | Kuniaki Takahashi | N. Kogame | Chun-Chin Chang | M. Tomaniak | S. Walsh | P. Vranckx | Y. Onuma | F. Krackhardt | D. Hildick-Smith | D. Adlam | E. Spitzer | Tessa Rademaker-Havinga | Pim van de Harst | P. Jüni | I. Edes | Norihiro Kogame